Redsense Medical announces company has begun trading on the OTCQX under ticker ‘RDSMF’
–News Direct–
Redsense Medical CEO Pontus Nobreus joined Steve Darling from Proactive to share significant updates regarding the company's innovative Redsense System. This system plays a crucial role in monitoring and alerting healthcare providers in cases of blood leakage during hemodialysis treatments, addressing one of the most serious safety concerns in this medical field.
The Redsense System comprises a patented fiber optic sensor designed for use with either a venous needle or central venous catheter, linked to an alarm unit. The system has been developed with a strong focus on meeting the stringent safety requirements of healthcare providers in the dialysis sector. Alarmingly, globally, 21 individuals lose their lives each week due to blood leakage during hemodialysis, mak...